BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 12195424)

  • 1. Targeted mutation of Cyln2 in the Williams syndrome critical region links CLIP-115 haploinsufficiency to neurodevelopmental abnormalities in mice.
    Hoogenraad CC; Koekkoek B; Akhmanova A; Krugers H; Dortland B; Miedema M; van Alphen A; Kistler WM; Jaegle M; Koutsourakis M; Van Camp N; Verhoye M; van der Linden A; Kaverina I; Grosveld F; De Zeeuw CI; Galjart N
    Nat Genet; 2002 Sep; 32(1):116-27. PubMed ID: 12195424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LIMK1 and CLIP-115: linking cytoskeletal defects to Williams syndrome.
    Hoogenraad CC; Akhmanova A; Galjart N; De Zeeuw CI
    Bioessays; 2004 Feb; 26(2):141-50. PubMed ID: 14745832
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of CYLN2 and GTF2IRD1 to neurological and cognitive symptoms in Williams Syndrome.
    van Hagen JM; van der Geest JN; van der Giessen RS; Lagers-van Haselen GC; Eussen HJ; Gille JJ; Govaerts LC; Wouters CH; de Coo IF; Hoogenraad CC; Koekkoek SK; Frens MA; van Camp N; van der Linden A; Jansweijer MC; Thorgeirsson SS; De Zeeuw CI
    Neurobiol Dis; 2007 Apr; 26(1):112-24. PubMed ID: 17270452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The murine CYLN2 gene: genomic organization, chromosome localization, and comparison to the human gene that is located within the 7q11.23 Williams syndrome critical region.
    Hoogenraad CC; Eussen BH; Langeveld A; van Haperen R; Winterberg S; Wouters CH; Grosveld F; De Zeeuw CI; Galjart N
    Genomics; 1998 Nov; 53(3):348-58. PubMed ID: 9799601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional, structural, and metabolic abnormalities of the hippocampal formation in Williams syndrome.
    Meyer-Lindenberg A; Mervis CB; Sarpal D; Koch P; Steele S; Kohn P; Marenco S; Morris CA; Das S; Kippenhan S; Mattay VS; Weinberger DR; Berman KF
    J Clin Invest; 2005 Jul; 115(7):1888-95. PubMed ID: 15951840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of dynein, dynactin, and CLIP-170 interactions in LIS1 kinetochore function.
    Tai CY; Dujardin DL; Faulkner NE; Vallee RB
    J Cell Biol; 2002 Mar; 156(6):959-68. PubMed ID: 11889140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conformational changes in CLIP-170 regulate its binding to microtubules and dynactin localization.
    Lansbergen G; Komarova Y; Modesti M; Wyman C; Hoogenraad CC; Goodson HV; Lemaitre RP; Drechsel DN; van Munster E; Gadella TW; Grosveld F; Galjart N; Borisy GG; Akhmanova A
    J Cell Biol; 2004 Sep; 166(7):1003-14. PubMed ID: 15381688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CLIP-170 facilitates the formation of kinetochore-microtubule attachments.
    Tanenbaum ME; Galjart N; van Vugt MA; Medema RH
    EMBO J; 2006 Jan; 25(1):45-57. PubMed ID: 16362039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterozygous deletion of the Williams-Beuren syndrome critical interval in mice recapitulates most features of the human disorder.
    Segura-Puimedon M; Sahún I; Velot E; Dubus P; Borralleras C; Rodrigues AJ; Valero MC; Valverde O; Sousa N; Herault Y; Dierssen M; Pérez-Jurado LA; Campuzano V
    Hum Mol Genet; 2014 Dec; 23(24):6481-94. PubMed ID: 25027326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haploinsufficiency of Gtf2i, a gene deleted in Williams Syndrome, leads to increases in social interactions.
    Sakurai T; Dorr NP; Takahashi N; McInnes LA; Elder GA; Buxbaum JD
    Autism Res; 2011 Feb; 4(1):28-39. PubMed ID: 21328569
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams' syndrome.
    Feyder M; Karlsson RM; Mathur P; Lyman M; Bock R; Momenan R; Munasinghe J; Scattoni ML; Ihne J; Camp M; Graybeal C; Strathdee D; Begg A; Alvarez VA; Kirsch P; Rietschel M; Cichon S; Walter H; Meyer-Lindenberg A; Grant SG; Holmes A
    Am J Psychiatry; 2010 Dec; 167(12):1508-17. PubMed ID: 20952458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Williams-Beuren syndrome: a model of recurrent genomic mutation.
    Pérez Jurado AL
    Horm Res; 2003; 59 Suppl 1():106-13. PubMed ID: 12638521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The contribution of CLIP2 haploinsufficiency to the clinical manifestations of the Williams-Beuren syndrome.
    Vandeweyer G; Van der Aa N; Reyniers E; Kooy RF
    Am J Hum Genet; 2012 Jun; 90(6):1071-8. PubMed ID: 22608712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced chromosome deletions cause hypersociability and other features of Williams-Beuren syndrome in mice.
    Li HH; Roy M; Kuscuoglu U; Spencer CM; Halm B; Harrison KC; Bayle JH; Splendore A; Ding F; Meltzer LA; Wright E; Paylor R; Deisseroth K; Francke U
    EMBO Mol Med; 2009 Apr; 1(1):50-65. PubMed ID: 20049703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role for regulated binding of p150(Glued) to microtubule plus ends in organelle transport.
    Vaughan PS; Miura P; Henderson M; Byrne B; Vaughan KT
    J Cell Biol; 2002 Jul; 158(2):305-19. PubMed ID: 12119357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haploinsufficiency of BAZ1B contributes to Williams syndrome through transcriptional dysregulation of neurodevelopmental pathways.
    Lalli MA; Jang J; Park JH; Wang Y; Guzman E; Zhou H; Audouard M; Bridges D; Tovar KR; Papuc SM; Tutulan-Cunita AC; Huang Y; Budisteanu M; Arghir A; Kosik KS
    Hum Mol Genet; 2016 Apr; 25(7):1294-306. PubMed ID: 26755828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and molecular characterization of the p24 dynactin light chain.
    Pfister KK; Benashski SE; Dillman JF; Patel-King RS; King SM
    Cell Motil Cytoskeleton; 1998; 41(2):154-67. PubMed ID: 9786090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of Gtf2ird1 from the Williams-Beuren syndrome critical region results in facial dysplasia, motor dysfunction, and altered vocalisations.
    Howard ML; Palmer SJ; Taylor KM; Arthurson GJ; Spitzer MW; Du X; Pang TY; Renoir T; Hardeman EC; Hannan AJ
    Neurobiol Dis; 2012 Mar; 45(3):913-22. PubMed ID: 22198572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracisternal Gtf2i Gene Therapy Ameliorates Deficits in Cognition and Synaptic Plasticity of a Mouse Model of Williams-Beuren Syndrome.
    Borralleras C; Sahun I; Pérez-Jurado LA; Campuzano V
    Mol Ther; 2015 Nov; 23(11):1691-1699. PubMed ID: 26216516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anxious, hypoactive phenotype combined with motor deficits in Gtf2ird1 null mouse model relevant to Williams syndrome.
    Schneider T; Skitt Z; Liu Y; Deacon RM; Flint J; Karmiloff-Smith A; Rawlins JN; Tassabehji M
    Behav Brain Res; 2012 Aug; 233(2):458-73. PubMed ID: 22652393
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.